Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

Clinical trial NCT05998759 · RECRUITING

Trial details

NCT number: NCT05998759
Sponsor: Beijing Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Connective Tissue Diseases Thrombocytopenia

Start date: 2023-12-02
Primary completion: 2025-12-01
Enrollment: 296

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.